Racial disparities and survival outcome of patients with locally advanced cervix cancer in the international randomised phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)

被引：0
|
作者：
Lee, Yeh Chen
Castellano, Tara
Myers, Tashanna K. N.
Barnes, Elizabeth H.
Chase, Dana Meredith
McCormick, Colleen
Diamante, Katrina
Shannon, Catherine M.
Huh, Warner King
Lea, Jayanthi Sivasothy
Walker, Joan L.
Small, William, Jr.
Miller, Katherine
Govindarajulu, Geetha
Monk, Bradley J.
Stockler, Martin R.
Moore, Kathleen N.
Mileshkin, Linda R.
Bae-Jump, Victoria Lin
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[2] Louisiana State Univ, Dept Gynecol Oncol, New Orleans, LA USA
[3] Baystate Med Ctr, Springfield, MA USA
[4] Univ Calif Los Angeles, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90024 USA
[5] Univ New Mexico Canc Ctr, Albuquerque, NM USA
[6] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[7] Mater Canc Care Ctr, South Brisbane, Australia
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[10] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA
[11] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[12] Women & Infants Hosp Rhode Isl, Providence, RI 02908 USA
[13] Calvary Mater Newcastle, Newcastle, NSW, Australia
[14] Univ Arizona Coll Med, HonorHlth Res Inst, Div Gynecol Oncol, Phoenix, AZ USA
[15] Creighton Univ Sch Med, Phoenix, AZ USA
[16] Univ Sydney, Camperdown, NSW, Australia
[17] Oklahoma Univ Hlth, Stephenson Canc Ctr, Oklahoma City, OK USA
[18] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[19] Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[20] Univ Melbourne, Melbourne, Vic, Australia
[21] Univ North Carolina Chapel Hill, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1594
引用
收藏
页数：1
相关论文
共 41 条
  • [1] Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
    Mileshkin, L.
    Barnes, E.
    Moore, K. N.
    Gebski, V.
    King, M.
    Narayan, K.
    Kolodziej, I. K.
    Sjoquist, K.
    Fyles, A.
    Small, W.
    Gaffney, D.
    Quinn, M.
    Andrews, J.
    Thompson, S.
    Huh, W.
    Carlson, M.
    Disilvestro, P. A.
    Rischin, D.
    Stockler, M. R.
    Monk, B. J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Disparities starting adjuvant chemotherapy for locally advanced cervical cancer in the international, academic, randomised, phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)
    Mileshkin, Linda
    Barnes, Elizabeth
    Moore, Kathleen
    Gebski, Val
    King, Madeleine
    Narayan, Kailash
    Kolodziej, Ilka
    Sjoquist, Katrin
    Fyles, Anthony
    Small, William
    Gaffney, David
    Quinn, Michael
    Andrews, John
    Thompson, Spencer
    Huh, Warner
    Miller, David
    Silvestro, Paul
    Rischin, Danny
    Stockler, Martin
    Monk, Bradley
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 178 - 179
  • [3] Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
    Mileshkin, Linda R.
    Moore, Kathleen N.
    Barnes, Elizabeth H.
    Lee, Yeh Chen
    Gebski, Val
    Narayan, Kailash
    Bradshaw, Nathan
    Diamante, Katrina
    Fyles, Anthony W.
    Small, William
    Gaffney, David K.
    Khaw, Pearly
    Brooks, Susan
    Thompson, J. Spencer
    Huh, Warner King
    Carlson, Matthew
    Robison, Katina
    Rischin, Danny
    Stockler, Martin R.
    Monk, Bradley J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).
    Mileshkin, Linda R.
    Moore, Kathleen N.
    Barnes, Elizabeth
    Gebski, Val
    Narayan, Kailash
    Bradshaw, Nathan
    Lee, Yeh Chen
    Diamante, Katrina
    Fyles, Anthony W.
    Small, William
    Gaffney, David K.
    Khaw, Pearly
    Brooks, Susan
    Thompson, J. Spencer
    Huh, Warner King
    Carlson, Matthew
    Mathews, Cara Amanda
    Rischin, Danny
    Stockler, Martin R.
    Monk, Bradley J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18)
  • [5] A phase III trial of adjuvant chemotherapy following chemoradialion as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/G0G0274/RTOG1174).
    Mileshkin, Linda R.
    Narayan, Kailash
    Moore, Kathleen N.
    Rischin, Danny
    King, Madeleine
    Kolodziej, Ilka
    Marlyn, Julie
    Friedlander, Michael
    Quinn, Michael
    Small, William
    Thomas, Gillian
    Fyles, Anthony W.
    Gebski, Vai
    Stockier, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
    Mileshkin, Linda R.
    Moore, Kathleen N.
    Barnes, Elizabeth H.
    Gebski, Val
    Narayan, Kailash
    King, Madeleine
    Bradshaw, Nathan
    Lee, Yeh Chen
    Diamante, Katrina
    Fyles, Anthony W.
    Small, William, Jr.
    Gaffney, David K.
    Khaw, Pearly
    Brooks, Susan
    Thompson, J. Spencer
    Huh, Warner K.
    Mathews, Cara A.
    Buck, Martin
    Suder, Aneta
    Lad, Thomas E.
    Barani, Igor J.
    Holschneider, Christine H.
    Van Dyk, Sylvia
    Quinn, Michael
    Rischin, Danny
    Monk, Bradley J.
    Stockler, Martin R.
    LANCET ONCOLOGY, 2023, 24 (05): : 468 - 482
  • [7] ADJUVANT CHEMOTHERAPY FOLLOWING CHEMORADIATION AS PRIMARY TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER COMPARED TO CHEMO-RADIATION ALONE: THE RANDOMISED PHASE 3 OUTBACK TRIAL
    Moore, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A6 - A6
  • [8] Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial
    Sun, Alexander
    Hu, Chen
    Wong, Stuart J.
    Gore, Elizabeth
    Videtic, Gregory
    Dutta, Swati
    Suntharalingam, Mohan
    Chen, Yuhchyau
    Gaspar, Laurie E.
    Choy, Hak
    JAMA ONCOLOGY, 2019, 5 (06) : 847 - 855
  • [9] Progression -Free Survival as a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial -Level Meta-Analysis and Individual -Level Analysis of NRG/RTOG 0617 and PROCLAIM
    Hu, C.
    Miccio, J. A.
    Dignam, J. J.
    Paulus, R.
    Liu, C.
    Skinner, H. D.
    Tsakiridis, T.
    Bradley, J. D.
    Machtay, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S128 - S128
  • [10] Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial
    McCormack, Mary
    Eminowicz, Gemma
    Gallardo, Dolores
    Diez, Patricia
    Farrelly, Laura
    Kent, Christopher
    Hudson, Emma
    Panades, Miguel
    Mathew, Tony
    Anand, Anjana
    Persic, Mojca
    Forrest, Jennifer
    Bhana, Rajanee
    Reed, Nicholas
    Drake, Anne
    Adusumalli, Madhavi
    Mukhopadhyay, Asima
    King, Margaret
    Whitmarsh, Karen
    McGrane, John
    Colombo, Nicoletta
    Mak, Choi
    Mandal, Ranajit
    Chowdhury, Rahul Roy
    Alamilla-Garcia, Gabriela
    Chavez-Blanco, Adriana
    Stobart, Hilary
    Feeney, Amanda
    Vaja, Simran
    Hacker, Anne-Marie
    Hackshaw, Allan
    Ledermann, Jonathan Andrew
    LANCET, 2024, 404 (10462): : 1525 - 1535
12345